Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension - Related Studies

Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension

This study is currently recruiting participants.

Study NCT00454207. Last updated on November 14, 2008. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pulmonary Hypertension

2	Additional conditions recognized in this trial
		Hypertension
		Hypertension, Pulmonary

3	More general conditions related to this trial
		Cardiovascular Diseases
		Lung Diseases
		Respiratory Tract Diseases
		Vascular Diseases

4	Interventions listed in this trial
		sildenafil citrate

5	Additional drug interventions recognized in this trial
		Sildenafil

6	More general drug interventions related to this trial
		Cardiovascular Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Phosphodiesterase Inhibitors
		Therapeutic Uses
		Vasodilator Agents

7	Sponsors listed in this trial
		Pfizer